What is the initial evaluation and treatment for a patient with suspected anemia, including the use of a comprehensive anemia (ana) panel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Evaluation of Suspected Anemia

Begin with a complete blood count (CBC) including hemoglobin, red cell indices (MCV, MCH, MCHC), white blood cell count with differential, platelet count, and absolute reticulocyte count, followed immediately by iron studies (serum ferritin and transferrin saturation) and vitamin B12 and folate levels. 1

Essential Laboratory Tests for Initial Workup

Core Anemia Panel

  • Hemoglobin is preferred over hematocrit because it has better reproducibility across laboratories and is not affected by sample storage time or patient glucose levels 2, 1
  • Complete blood count assesses bone marrow function across all cell lines; abnormalities in two or more cell lines warrant hematology consultation 2, 1
  • Absolute reticulocyte count is essential to assess bone marrow response—a low count indicates impaired erythropoiesis (common in iron deficiency), while an elevated count suggests hemolysis or acute blood loss 2, 3, 1

Iron Studies

  • Serum ferritin is the single most useful marker for iron stores 2, 3, 1

    • Ferritin <30 μg/L confirms iron deficiency in the absence of inflammation 3, 1
    • Ferritin <45 ng/mL defines iron deficiency anemia when combined with low hemoglobin 2
    • Critical pitfall: Ferritin is an acute phase reactant and can be falsely elevated in inflammation, chronic disease, malignancy, or liver disease 2, 1
    • In the presence of inflammation, ferritin up to 100 μg/L may still indicate iron deficiency 3
  • Transferrin saturation (TSAT) helps identify iron availability for erythropoiesis 3, 1

    • TSAT <20% supports iron deficiency 2
    • TSAT <15-16% is particularly specific for iron deficiency and is less affected by inflammation than ferritin 1
    • Useful when ferritin results may be falsely normal due to inflammation 3

Additional Essential Tests

  • Vitamin B12 and folate levels must be obtained to rule out deficiencies that may contribute to or cause anemia 2, 1
  • Serum creatinine and GFR to evaluate for chronic kidney disease as a cause of anemia 2

Interpretation Based on Red Cell Indices

Microcytic Anemia (MCV <80 fL)

  • Most commonly indicates iron deficiency anemia, the most prevalent cause of anemia globally 1
  • Low MCH and MCHC suggest hypochromic anemia, strongly associated with iron deficiency 3

Normocytic Anemia (MCV 80-100 fL)

  • May indicate hemorrhage, hemolysis, or anemia of chronic inflammation 1
  • The anemia of chronic kidney disease is typically normochromic and normocytic 2

Macrocytic Anemia (MCV >100 fL)

  • Suggests vitamin B12 or folate deficiency 1

Specific Diagnostic Thresholds

Defining Anemia

  • Men: Hemoglobin <13 g/dL 2
  • Non-pregnant women: Hemoglobin <12 g/dL 2
  • Use the lower limit of normal for the relevant population and laboratory performing the test 2

Confirming Iron Deficiency Anemia

Iron deficiency anemia is present when BOTH criteria are met 2:

  • Hemoglobin below threshold (as above) AND
  • Ferritin <45 ng/mL (or <30 μg/L without inflammation)

Additional Workup Based on Initial Results

If Iron Deficiency is Confirmed

For men and postmenopausal women 2:

  • Perform non-invasive testing for H. pylori and celiac disease 2
  • Strong recommendation: Proceed with bidirectional endoscopy (gastroscopy and colonoscopy) to evaluate for gastrointestinal malignancy and bleeding sources 2
  • Celiac disease is found in 3-5% of iron deficiency anemia cases and should be routinely screened serologically 2

For premenopausal women 2:

  • Conditional recommendation for endoscopy given lower prevalence of neoplasia
  • Those who place high value on avoiding endoscopy risks may reasonably select initial empiric iron supplementation alone 2
  • However, if symptoms are present or iron supplementation fails, endoscopic evaluation is indicated 2

If Bidirectional Endoscopy is Unrevealing

  • Consider video capsule endoscopy to evaluate the small bowel, particularly in patients requiring antiplatelet or anticoagulant therapy 2
  • Capsule endoscopy is the preferred test for examining the small bowel because it is highly sensitive for mucosal lesions 2

If Iron Studies Show Elevated Ferritin with Low TSAT

  • Consider anemia of chronic inflammation/disease 1
  • Measure C-reactive protein to assess the contribution of inflammation to elevated ferritin 1
  • Treat the underlying condition; erythropoietin therapy may be considered in specific situations such as chronic kidney disease 1

Treatment Initiation

Iron Replacement Therapy

  • Oral iron in divided doses is first-line for most patients 2
  • Intravenous iron should be used if 2:
    • Intolerance to oral iron
    • Gastrointestinal uptake problems (e.g., hepcidin elevation)
    • Short timeline before surgery
    • Malabsorption of oral iron

Response Assessment

  • A good response to iron therapy (hemoglobin rise ≥10 g/L within 2 weeks) is highly suggestive of absolute iron deficiency, even if iron studies are equivocal 2
  • Check hemoglobin at one month; if there is not a 1-2 g/dL increase, consider malabsorption, continued bleeding, or an unknown lesion 4
  • Continue hemoglobin monitoring and ensure iron stores are restored (ferritin >100 ng/mL) 2

If No Response to Iron Therapy

  • Investigate for ongoing blood loss 2
  • Consider small bowel evaluation with capsule endoscopy 2
  • Evaluate renal tract for other causes 2
  • Consider bone marrow aspiration and biopsy when initial workup is unrevealing 1

Critical Pitfalls to Avoid

  • Do not miss inflammation-masked iron deficiency: Ferritin can be falsely normal or elevated despite true iron deficiency in inflammatory states, chronic disease, malignancy, or liver disease 2, 3, 1
  • Do not delay gastrointestinal evaluation in high-risk patients: 9% of patients older than 65 years with iron deficiency anemia have gastrointestinal cancer 4
  • Do not assume menstruation explains iron deficiency in premenopausal women without further evaluation if symptoms are present or treatment fails 2
  • Do not overlook celiac disease: Screen all patients with iron deficiency anemia for celiac disease 2

References

Guideline

Diagnostic Approach to Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anemia Evaluation and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Iron deficiency anemia.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.